Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

KBTBD11 Inhibitors

The chemical class known as KBTBD11 Inhibitors encompasses a range of compounds designed to modulate the activity of the Kelch Repeat and BTB (POZ) Domain Containing 11 protein. These inhibitors are primarily characterized by their ability to interfere with the functional mechanisms of KBTBD11, which may include disrupting its protein-protein interactions, hindering its role in ubiquitination processes, or altering its regulatory pathways. The diversity of these compounds reflects the complex nature of targeting a protein that is involved in multiple cellular functions, including protein degradation, signaling, and possibly gene expression regulation. The inhibitors might act by directly binding to KBTBD11, thereby blocking its interaction with other proteins, or they might influence the upstream signaling pathways or post-translational modifications that control the activity or stability of KBTBD11.

Given the involvement of KBTBD11 in various cellular processes, the impact of inhibiting this protein can be significant and widespread. By modulating the activity of KBTBD11, these inhibitors can alter the ubiquitination and degradation of key regulatory proteins, thereby affecting cellular homeostasis, response to stress, and other critical cellular functions. The specific effects of these inhibitors depend on the nature of their interaction with KBTBD11 and the cellular context in which they are used. The development and study of KBTBD11 inhibitors require an understanding of the protein's structure, the dynamics of its interactions, and the cellular pathways in which it is involved. Researchers aim to identify inhibitors with high specificity and potency, minimizing off-target effects and maximizing the desired modulation of KBTBD11 activity. As our understanding of KBTBD11 and its role in cellular physiology expands, so too will the sophistication and efficacy of the inhibitors designed to modulate its activity, offering potential insights into protein regulation, signaling, and the complex interplay of cellular mechanisms.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Could possibly inhibit KBTBD11 by preventing the degradation of its substrates or regulatory proteins via proteasome inhibition.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

Could possibly inhibit KBTBD11 by affecting cullin-RING ligase activity, as some BTB domain proteins are part of these complexes, via NEDD8-activating enzyme inhibition.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Could possibly inhibit KBTBD11 by reducing the degradation of proteins regulated by it, thus affecting its functional pathways via proteasome inhibition.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Could possibly inhibit KBTBD11 by affecting the turnover of proteins regulated by it, altering its pathway activities via proteasome inhibition.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

Could possibly inhibit KBTBD11 by disrupting the ubiquitination process via inhibition of ubiquitin-activating enzyme E1.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Could possibly inhibit KBTBD11 by inhibiting the degradation of its substrates, impacting its function via specific proteasome inhibition.

Withaferin A

5119-48-2sc-200381
sc-200381A
sc-200381B
sc-200381C
1 mg
10 mg
100 mg
1 g
$127.00
$572.00
$4090.00
$20104.00
20
(1)

Could possibly inhibit KBTBD11 by inhibiting proteasomal activity, possibly affecting KBTBD11-mediated protein degradation.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$134.00
$215.00
$440.00
$496.00
19
(2)

Could possibly inhibit KBTBD11 by altering proteasomal degradation pathways, impacting its function via selective proteasome inhibition.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Could possibly inhibit KBTBD11 through multiple pathways, including inhibition of protein interactions or signaling pathways, given its broad biological effects.

Celastrol, Celastrus scandens

34157-83-0sc-202534
10 mg
$155.00
6
(1)

Could possibly inhibit KBTBD11 by affecting proteasomal activity, possibly influencing KBTBD11 activity or its substrates via triterpenoid action.